Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Neurology | Psychiatry/Psychology | Family Medicine
Search Medical Condition
Depression Clinical Trials
A listing of Depression medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (1207) clinical trials
Major Depression Research Study
Not satisfied with your current antidepressant? Consider a research study of an investigational medication that is given by injection once a month in addition to your current antidepressant. Compensation up to $600.00 is available for time & travel for this 8 visit study over approximately 26 weeks. This study is ...
A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder
The purpose of this study is to evaluate the efficacy, safety, and tolerability of levomilnacipran ER relative to placebo in adolescent outpatients (12-17 years) with Major Depressive Disorder (MDD). In addition, the study is designed to obtain pharmacokinetics (PK) data to guide dose selection for future pediatric studies of levomilnacipran.
Treatment Resistant Depression Study
A randomized, double-blind, active-controlled, multicenter study in male and female adult subjects with TRD to assess the efficacy, safety, and tolerability of flexibly dosed intranasal esketamine plus a newly initiated oral antidepressant compared with a newly initiated oral antidepressant plus intranasal placebo
A Phase 3 Multicenter Study of the Long-term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults who Have an Inadequate Response to Antidepressant Therapy
To assess the long-term safety and tolerability of ALKS 5461 for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD)
A Phase 3 Efficacy and Safety Study of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder
To evaluate the efficacy of ALKS 5461 for the adjunctive treatment of major depressive disorder (MDD) in adults who have an inadequate response to antidepressant therapy (ADT). To evaluate the safety and tolerability of ALKS 5461 in adults who have MDD and an inadequate response to ADT.
A Randomized, Double-Blind, Placebo-Controlled, Phase 4, Relapse Prevention Study Evaluating the Efficacy and Safety of Vortioxetine (5, 10 and 20 mg) in Adults With Major Depressive Disorder
This study is a randomized, double-blind, placebo-controlled study to evaluate 3 fixed doses (5, 10, and 20 mg oral tablets) of vortioxetine once daily in the prevention of relapse in adult subjects with major depressive disorder (MDD) who have responded to acute treatment with vortioxetine.
A Phase 3, Doulbe-Blind, Placebo-Controlled Study of Cariprazine as Adjunctive Therapy in Major Depressive Disorder
To evaluate the efficacy, safety and tolerability of Cariprazine as an adjunctive treatment to antidepressant therapy (ADT) in patients with MDD
A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subjects with Treatment-resistant Depression
This is a study of subjects with TRD to assess the efficacy, safety, and tolerability of intranasal esketamine plus an oral antidepressant compared to an oral antidepressant (active comparator) plus intranasal placebo.
PROJECT ID: SGE736MR-157368
To determine if SAGE-547 Injection infused intravenously for 60 hours reduces depressive symptoms in subjects with postpartum depression (PPD) compared to placebo injection
Adolescent Non-Drug Depression Study: A randomized, sham-controlled trial Evaluating the Safety and Effectiveness of ---- device in depressed adolescents
Adolescent Non-Drug Depression Study designed to study the safety and effectiveness of a non-drug treatment in adolescents with Major Depressive Disorder.
